Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

Corporate Presentation services provided by Aptra Synthesis

Aptra Synthesis
Corporate Presentation
Full Screen View

PDF Upload Nov, 2024

US FDA approves Syndax's blood cancer drug

16 Nov 2024

// REUTERS

Eyenovia to end eye drug study, cut 50% of its workforce

16 Nov 2024

// REUTERS

Drugmaker stocks slide as Trump taps RFK Jr for US health job

16 Nov 2024

// REUTERS

DATA COMPILATION
#PharmaFlow

Aptra Synthesis

Contact Supplier

CPhI India 2024

Attending

Book a meeting

envelop Contact Supplier

Latest Content by PharmaCompass

radio-compass-blog/medical-breakthroughs-in-2024-alzheimer-s-schizophrenia-copd-mash-see-pathbreaking-treatments

Xls

CATEGORY PAGE

Aptra Synthesis

VISIT THE VIRTUAL BOOTH, Contact Details

VISIT THE VIRTUAL BOOTH
Review portfolio & marketing content
CONTACT DETAILS
Google Map, LinkedIn, Emails...

EVENTS

Webinars & Exhibitions

Webinars & Exhibitions

PRESENTATION(s)

Product List 2024, Corporate Presentation, API Product List 2024, Intermediates Product List 2024

Product List 2024
Corporate Presentation
API Product List 2024
Intermediates Product List 2024

DIGITAL CONTENT

4 CORPORATE CONTENT #SupplierSpotlight

4 CORPORATE CONTENT #SupplierSpotlight

ACTIVE PHARMA INGREDIENTS

38 All APIs, 38 Listed APIs

38 All APIs
38 Listed APIs

INTERMEDIATES

40 ALL Intermediates

40 ALL Intermediates

KEY PRODUCTS

Clopidogrel, Clopidogrel Besylate, Clopidogrel Hydrochloride, Lacosamide, Olmesartan Medoxomil, Telmisartan

Clopidogrel
Clopidogrel Besylate
Clopidogrel Hydrochloride
Lacosamide
Olmesartan Medoxomil
Telmisartan

PC110632

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
LOOKING FOR A SUPPLIER?